|
|
|
|
| LEADER |
00000cam a2200000 4500 |
| 001 |
1616759666 |
| 003 |
DE-627 |
| 005 |
20230426171816.0 |
| 007 |
tu |
| 008 |
931006s1992 xx ||||| 00| ||eng c |
| 020 |
|
|
|a 1560242507
|9 1-56024-250-7
|
| 035 |
|
|
|a (DE-627)1616759666
|
| 035 |
|
|
|a (DE-576)035441682
|
| 035 |
|
|
|a (DE-599)BSZ035441682
|
| 035 |
|
|
|a (OCoLC)24378036
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 616.865061
|
| 245 |
1 |
0 |
|a Nicotine replacement
|b a critical evaluation
|c Ovide F. Pomerleau ... (eds.)
|
| 264 |
|
1 |
|a New York [u.a.]
|b Pharmaceutical Products Pr.
|c 1992
|
| 300 |
|
|
|a 317 S.
|b graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 1
|2 pdager
|
| 655 |
|
7 |
|a Konferenzschrift
|0 (DE-588)1071861417
|0 (DE-627)826484824
|0 (DE-576)433375485
|2 gnd-content
|
| 700 |
1 |
|
|a Pomerleau, Ovide F.
|e Hrsg.
|4 edt
|
| 951 |
|
|
|a BO
|
| ELC |
|
|
|b 1
|
| LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
| LOK |
|
|
|0 001 3202727486
|
| LOK |
|
|
|0 003 DE-627
|
| LOK |
|
|
|0 004 1616759666
|
| LOK |
|
|
|0 005 20151006103647
|
| LOK |
|
|
|0 008 931006||||||||||||||||ger|||||||
|
| LOK |
|
|
|0 040
|a DE-21
|c DE-627
|d DE-21
|
| LOK |
|
|
|0 852
|a DE-21
|
| LOK |
|
|
|0 852 1
|c KB 19 A 947
|9 00
|
| LOK |
|
|
|0 935
|a krim
|
| ORI |
|
|
|a SA-MARC-krimdoka001.raw
|
| SIG |
|
|
|a UB: KB 19 A 947
|
